{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:21:11Z","timestamp":1765887671264,"version":"3.37.3"},"reference-count":31,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,2,20]],"date-time":"2015-02-20T00:00:00Z","timestamp":1424390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidemiology and Drug"],"published-print":{"date-parts":[[2015,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Purpose<\/jats:title><jats:p>This study aims to explore the influence of gestational age at enrollment, and enrollment before or after prenatal screening, on the estimation of drug effects in pregnancy exposure registries.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We assessed the associations between first trimester antiepileptic drug (AED) exposure and risk of spontaneous abortion and major congenital malformations in the North American AED Registry (1996\u20132013). We performed logistic regression analyses, conditional or unconditional on gestational age at enrollment, to estimate relative risk (RR) for first trimester AED users compared with non\u2010users. We also compared first trimester users of valproic acid and lamotrigine. Analyses were repeated in women who enrolled before prenatal screening.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Enrollment occurred earlier among 7029 AED users than among 581 non\u2010users; it was similar among AEDs. Comparing AED users with non\u2010users, RR (95% confidence interval) of spontaneous abortion (<jats:italic>n<\/jats:italic>\u2009=\u2009359) decreased from 5.1 (2.3\u201314.1) to 2.0 (0.9\u20135.6) after conditioning on gestational week at enrollment and to 1.9 (0.8\u20135.4) upon further restriction to before\u2010screening enrollees. RR of congenital malformations (<jats:italic>n<\/jats:italic>\u2009=\u2009216) changed from 3.1 (1.4\u20138.5) to 3.2 (1.4\u20139.0) after conditioning on gestational week at enrollment and to 2.0 (0.7\u201310.1) upon further restriction to before\u2010screening enrollees. When comparing valproic acid users and lamotrigine users, the RR of congenital malformations was not substantially changed by conditioning or restricting.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Spontaneous abortion rates were sensitive to gestational age at enrollment. Estimates of congenital malformation risks for AED users relative to non\u2010users were sensitive to before\/after\u2010screening enrollment. This difference was not apparent between active drugs, likely due to similar gestational age at enrollment. Copyright \u00a9 2015 John Wiley &amp; Sons, Ltd.<\/jats:p><\/jats:sec>","DOI":"10.1002\/pds.3731","type":"journal-article","created":{"date-parts":[[2015,2,20]],"date-time":"2015-02-20T13:47:07Z","timestamp":1424440027000},"page":"343-352","source":"Crossref","is-referenced-by-count":22,"title":["Effects of gestational age at enrollment in pregnancy exposure registries"],"prefix":"10.1002","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7388-6082","authenticated-orcid":false,"given":"Andrea V.","family":"Margulis","sequence":"first","affiliation":[{"name":"Department of Epidemiology Harvard School of Public Health  Boston MA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murray A.","family":"Mittleman","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Harvard School of Public Health  Boston MA USA"},{"name":"Cardiovascular Epidemiology Research Unit Beth Israel Deaconess Medical Center  Boston MA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Glynn","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Harvard School of Public Health  Boston MA USA"},{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics Brigham and Women's Hospital  Boston MA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lewis B.","family":"Holmes","sequence":"additional","affiliation":[{"name":"North American AED Pregnancy Registry, Medical Genetics Unit MassGeneral Hospital for Children  Boston MA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Hern\u00e1ndez\u2010D\u00edaz","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Harvard School of Public Health  Boston MA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,2,20]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60257-7"},{"key":"e_1_2_8_3_1","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER).Reviewer Guidance: Evaluating the Risks of Drug Exposure in Human Pregnancies.2005."},{"key":"e_1_2_8_4_1","unstructured":"Committee for Medicinal Products for Human Use (CHMP) European Medicines Agency.Guideline on the Exposure to Medicinal Products during Pregnancy: Need for Post\u2010Authorisation Data.2005."},{"volume-title":"Registries for Evaluating Patient Outcomes: A User's Guide","year":"2010","author":"Gliklich RE","key":"e_1_2_8_5_1"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200427040-00001"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000316199.92256.af"},{"key":"e_1_2_8_8_1","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER).Guidance for Industry: Establishing Pregnancy Exposure Registries.2002."},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwk027"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2008.06.006"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3301"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.61.5.673"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0013-9580.2004.451102.x"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2010.02525.x"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20842"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2009.11.008"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907328"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182574f39"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9926(199901)59:1<1::AID-TERA1>3.0.CO;2-L"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1988.tb03745.x"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.23014"},{"key":"e_1_2_8_22_1","unstructured":"RothmanK.Episheet: Spreadsheets for the analysis of epidemiologic data.http:\/\/www.drugepi.org\/wp\u2010content\/uploads\/2012\/10\/Episheet.xls(accessed March 17 2011)."},{"issue":"15","key":"e_1_2_8_23_1","first-page":"1","article-title":"Estimated pregnancy rates by outcome for the United States, 1990\u20132004","volume":"56","author":"Ventura SJ","year":"2008","journal-title":"Natl Vital Stat Rep"},{"issue":"7","key":"e_1_2_8_24_1","first-page":"1","article-title":"Estimated pregnancy rates and rates of pregnancy outcomes for the United States, 1990\u20132008","volume":"60","author":"Ventura SJ","year":"2012","journal-title":"Natl Vital Stat Rep"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2006.10.015"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050372"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwm324"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/ppe.12073"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwq481"},{"volume-title":"Applied Regression Analysis and Other Multivariable Methods","year":"2007","author":"Kleinbaum D","key":"e_1_2_8_30_1"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.23271"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200831010-00004"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.3731","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.3731","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pds.3731","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T03:25:57Z","timestamp":1696476357000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.3731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,20]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["10.1002\/pds.3731"],"URL":"https:\/\/doi.org\/10.1002\/pds.3731","archive":["Portico"],"relation":{},"ISSN":["1053-8569","1099-1557"],"issn-type":[{"type":"print","value":"1053-8569"},{"type":"electronic","value":"1099-1557"}],"subject":[],"published":{"date-parts":[[2015,2,20]]}}}